Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 178
- 试验地点
- 1
- 主要终点
- Preferred treatment/control frequency for patients with advanced prostate cancer
研究概览
简要总结
Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval.
Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •A diagnosis of advanced prostate cancer
- •Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)
排除标准
- •Inability to read/write Danish
结局指标
主要结局
Preferred treatment/control frequency for patients with advanced prostate cancer
时间窗: Up to 1 year
Preferred treatment frequency is assessed by patient answers to the question: "If treatments were equally effective from a medical standpoint - How often would you then prefer to receive treatment"
次要结局
- Treatment satisfaction(Up to 1 year)
- Side effects to treatment(Up to 1 year)
- Treatment satisfaction, preferred frequency of clinical control, and side effects after surgical castration(Up to 1 year)